Market niche Bio-Me specializes in microbiome analysis with a focus on Precision Microbiome Profiling (PMP) for gut, skin, and vaginal microbiomes, presenting a targeted opportunity to sell specialized analytics services to healthcare institutions, pharma, and consumer care companies seeking microbiome insights.

Custom assay potential Their platform supports custom development of standardized and validated microbiome assays, enabling upsell to clients needing tailored, compliant testing workflows and regulatory-ready solutions.

Regional access Based in Oslo with global partnerships, there is potential to leverage Northern Europe access and European healthcare networks to expand into EU research collaborations and translational studies.

SMB-friendly positioning Small to mid-sized firm size (11-50 employees) and revenue in the low range suggests a sales approach emphasizing scalable services, flexible pricing, and pilot programs to win long-term contracts with institutions and biotech firms.

Competitive edge Proprietary PMP assay design database and rapid, cost-competitive analysis position Bio-Me to compete on speed, specificity, and total cost of ownership for routine microbiome testing among healthcare and consumer health players.